KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
No Result
View All Result
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
No Result
View All Result
Home Bioneer

Bioneer’s Molecular Diagnostic Equipment Attracts Global Attention

 1,694 total views,  1 views today

KoreaTechToday Editor by KoreaTechToday Editor
PUBLISHED: May 20, 2020 UPDATED: May 21, 2020
in Bioneer, Biotech, Coronavirus, Healthcare, Indonesia, South Korea
0
Bioneer's test kit reader ExiStation 48. / photo courtesy of Bioneer
Bioneer's test kit reader ExiStation 48. / photo courtesy of Bioneer

Bioneer's test kit reader ExiStation 48. / photo courtesy of Bioneer

Bioneer Co., a South Korean biotech firm, on Wednesday, said that it signed a memorandum of understanding (MOU) to source COVID-19 test kit readers valued at 6.8 billion won ($5.5 million) to Indonesia-based Genomik Solidaritas.

Established in 1992, Bioneer is the first South Korean biotechnology venture founded by CEO Park Han-oh. The company specializes in molecular biology products and technologies with the aim of localizing biotechnology research technology. It operates a head office in Daejeon with a factory located in Cheongju.

Under the MOU, Bioneer would produce 25 sets of ExiStation 48. The delivery would include RT-PCR COVID-19 test kits and nucleic acid diagnostic agents.

The company would first deliver nine ExiStation 48s and kits valued at 1.5 billion won ($1.22 million), with the remaining batch following demand in Indonesia.

The biotech firm hopes to help significantly Indonesian medical professionals with its ExiStation test kit readers amid the COVID-19 pandemic.

Expanding Global Presence

The company increased its presence globally for its exclusive RT-PCR molecular diagnostic equipment for COVID-19. Park said that the demand for such equipment has doubled or tripled as compared last year.

He said that the company successfully marketed about 1,000 units worldwide and about 150 units in Korea. Bioneer also actively introduced its diagnostic equipment and reagents to domestic diagnosis companies, hospitals, and life science businesses.

According to Park, Bioneer is the only Asian company to acquire European certification (CE-IVD) for the molecular diagnosis of COVID-19. He added that Bioneer is also the only domestic company to localize expensive diagnostic equipment successfully.

However, multinational pharmaceutical companies such as Abbott and Roche monopolize the domestic market for assays, which could reach 185 million won ($150,000) to 431 million won ($350,000) per unit.

Park said that a COVID-19 therapeutics is also under development. Based on Bioneer’s DNA synthesis technology, the company produced 980 types of candidate molecules that could combat and neutralize COVID-19 faster.

Bioneer recently tested animal models with therapy for inhibiting pulmonary fibrosis in COVID-19 patients. The company said it would soon evaluate human clinical trials within the year.

The Bioneer CEO said that the therapeutics would become a first-in-class drug target DNA sequences.

What’s your thoughts?
+1
0
+1
0
+1
0
+1
0
+1
0
+1
0
+1
0
Tags: BioneercoronavirusCOVID-19diagnosticExiStationGenomik SolidaritasIndonesiaMOUreadertest kittherapeutics

Related Posts

AMSBIO to revolutionize Korea’s diagnostic market with saliva-based cancer diagnosis technology
Bioneer's test kit reader ExiStation 48. / photo courtesy of Bioneer
Biotech

AMSBIO to revolutionize Korea’s diagnostic market with saliva-based cancer diagnosis technology

March 27, 2023
South Korea gears up to bring World Expo 2030 to Busan
Bioneer's test kit reader ExiStation 48. / photo courtesy of Bioneer
South Korea

South Korea gears up to bring World Expo 2030 to Busan

March 11, 2023
GC Biopharma to launch first-in-class rare disorder medications in the global market
Bioneer's test kit reader ExiStation 48. / photo courtesy of Bioneer
Healthcare

GC Biopharma to launch first-in-class rare disorder medications in the global market

March 2, 2023
Samsung headquarters
Bioneer's test kit reader ExiStation 48. / photo courtesy of Bioneer
South Korea

Korea’s top 100 companies’ economic contribution soar by 20%  in 9 years

July 20, 2022
South Korea curbs tech leaks to foreign countries
Bioneer's test kit reader ExiStation 48. / photo courtesy of Bioneer
South Korea

South Korea curbs tech leaks to foreign countries

February 8, 2022
Hyundai Rotem set to provide upgraded army tank variants to South Korea
Bioneer's test kit reader ExiStation 48. / photo courtesy of Bioneer
South Korea

Hyundai Rotem set to provide upgraded army tank variants to South Korea

February 2, 2022
No Result
View All Result

Follow Us

FREE NEWSLETTER




PRODUCTS

Most Popular

  • 5 Best Korean to English Translation Apps

    0 shares
    Share 0 Tweet 0
  • Top South Korean Tech Products to Look Out for in 2021

    0 shares
    Share 0 Tweet 0
  • Robots to help Police Patrol in South Korea

    0 shares
    Share 0 Tweet 0
  • 5 All-Time Best Rom-Com K-Dramas to Watch

    0 shares
    Share 0 Tweet 0
  • South Korea plans Urban Air Mobility Air Taxi services by 2025

    0 shares
    Share 0 Tweet 0
  • SK On to introduce South Korea’s first LFP Battery Prototype

    0 shares
    Share 0 Tweet 0
  • Outsourcing by Samsung to China Feared by Phone Parts Suppliers

    0 shares
    Share 0 Tweet 0
  • South Korea to commercialize Quantum Cryptography Communications

    0 shares
    Share 0 Tweet 0
  • Top Eight Promising EdTech Startup Companies in South Korea

    0 shares
    Share 0 Tweet 0
  • Netmarble subsidiary Metaverse Entertainment’s K-Pop virtual girl band MAVE has a smashing online debut

    0 shares
    Share 0 Tweet 0
  • About Us
  • Account Page
  • application form
  • Cookie policy
  • Default Redirect Page
  • homepage
  • Login
  • login form
  • LogOut
  • Newsletter
  • Privacy Policy
  • Register
  • Reset Password
  • Sample Page
  • Subscription Plan
  • Terms of Use
  • test
  • test
  • testpage
  • TOS Page
  • Visitor Inside User Page

Copyright © 2023 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |

No Result
View All Result
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government

Copyright © 2023 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |